Stay updated with breaking news from Launch Products. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Takeda TOKYO4502NYSETAK today announced financial results for the first half of fiscal year 2023 six months ended September 30 2023 updating reported and Core forecasts and reconfirming Management Guidance for Core change at CER.
Takeda TOKYO4502NYSETAK today announced strong financial results for the first quarter of fiscal year 2023 period ended June 30 2023.
Takeda Pharmaceutical Co Ltd's (NYSE: TAK) Q1 FY23 net profit rose 4.1% (+0.9% at CER) to ¥233.4 billion, driven by
Letter to Shareholders1 May 2023 Christophe Weber President & CEO ... | May 30, 2023
Full Year Reported Revenue Growth of +12.8%; Core Revenue Growth of +3.5% at Constant Exchange Rate Driven by Growth & Launch Products; Reported EPS Growth of +38.8% Achieved Core Operating... | May 11, 2023